Amgen’s Growth Potential Affirmed: Buy Rating with Increased …

Amgen’s Growth Potential Affirmed: Buy Rating With Increased …

2 weeks from now

Oct 21, 2024  · Yaron Werber has given his Buy rating due to a combination of factors affecting Amgen’s stock. Primarily, the increase in the price target to $383 reflects a positive outlook, driven by a slight ...

businessinsider.com

Strong Buy Rating For Amgen Amidst Impressive Growth And …

2 weeks from now

Oct 30, 2024  · These factors combined present a strong case for the Buy rating on Amgen’s stock. According to TipRanks , Werber is a 5-star analyst with an average return of 14.0% and …

businessinsider.com

Amgen Q4 Earnings: Strong Pipeline And Label Expansions Justify …

2 weeks from now

As such, Amgen's continued sales growth justifies a BUY rating. A 12-month price target of 5.6x the midpoint of 2025 sales guidance justifies a market capitalization of $196B or $365/share in …

seekingalpha.com

Amgen (AMGN) Stock Forecast And Price Target 2025 - MarketBeat

2 weeks from now

4 days ago  · The company has shown significant revenue growth, with a year-over-year increase of 23.2%, reflecting its ability to expand its market presence and product offerings. ... Analysts …

marketbeat.com

Amgen: The Buying Opportunity Has Now Arrived (Rating Upgrade)

2 weeks from now

Amgen's sales of its seven innovative products posted 17% year-over-year sales growth in the third quarter. These products contributed to more than $2 billion in sales for the period.

seekingalpha.com

Amgen Shares Keep Buy Rating As Analyst Updates Model Ahead Of …

2 weeks from now

Oct 21, 2024  · On Monday, TD Cowen maintained a Buy rating on Amgen (NASDAQ: AMGN) and slightly raised the price target to $383 from $381.The adjustment reflects an updated valuation …

investing.com

Goldman Sachs Backs Amgen Shares With Buy Rating, Emphasizing …

2 weeks from now

Jan 8, 2025  · On Wednesday, Goldman Sachs reaffirmed its Buy rating and $370.00 price target for Amgen (NASDAQ: AMGN) shares. The firm's analyst, Salveen Richter, provided insights …

investing.com

Amgen: Blockbusters, Emerging Therapies, And Investment Potential

2 weeks from now

Jan 6, 2025  · This contribution propelled the revenues driven by Amgen’s rare disease therapeutic area, which observed a 21% YoY growth in Q3 2024. Amgen’s 9M 2024 financial …

seekingalpha.com

Erste Group Lifts Amgen Stock Rating To Buy On Strong Margins

2 weeks from now

2 days ago  · Cantor Fitzgerald reduced its price target for Amgen from $405 to $340 due to a clinical hold on Amgen's AMG 513. Despite the hold, the firm retained its Overweight rating on …

investing.com

Amgen Sustains Buy Rating, Stock Target Amid Pipeline Updates

2 weeks from now

Sep 25, 2024  · Amgen sustains buy rating, stock target amid pipeline updates Open in App. Get 60% Off. Sign In ... highlighting the potential competitive edge of Uplizna in the gMG market. …

investing.com

Amgen Inc.'s Stock Price Soars To $307.81, Marking A Robust 6.50% ...

2 weeks from now

1 day ago  · Furthermore, Baptista Research also analyzed Amgen’s second quarter 2024 financial results, which saw a 20% year-over-year increase in revenue to $8.4 billion. The …

smartkarma.com

Are Wall Street Analysts Predicting Amgen Stock Will Climb Or Sink?

2 weeks from now

3 days ago  · Amgen's shares recovered 1.5% following its Q3 earnings release on Oct. 30 due to the company’s stronger-than-expected adjusted EPS of $5.58. The revenue growth of 23% …

nasdaq.com

Robust Portfolio And Strategic Growth Initiatives Justify Buy Rating ...

2 weeks from now

Oct 4, 2024  · Amgen’s non-GAAP earnings per share showed a 6% year-over-year increase, meeting market expectations, and the company has confidently raised its revenue guidance …

businessinsider.com

Goldman Sachs Retains Amgen Buy Stock Rating On Clinical Trial

2 weeks from now

Jan 15, 2025  · On Wednesday, Goldman Sachs reiterated its Buy rating on Amgen stock (NASDAQ:AMGN), maintaining a price target of $370.00. The biotechnology giant, with a …

investing.com

2 Reasons To Buy Amgen Stock, And 1 Reason To Be Cautious

2 weeks from now

Nov 16, 2024  · While Amgen's (AMGN 0.05%) shares have underperformed the market over the past 12 months, climbing 19.7% compared to the market's unusually large gain of 35.6%, …

fool.com

Cautious Outlook On Amgen: Sell Rating Amid Modest Growth

2 weeks from now

1 day ago  · In a report released today, Tim Anderson from Bank of America Securities reiterated a Sell rating on Amgen (AMGN – Research Report), with a price target of $275.00. Maximize …

tipranks.com

Buy Rating Affirmed: Amgen’s Strategic Advancements In Obesity …

2 weeks from now

Oct 3, 2024  · AMGN’s price has also changed moderately for the past six months – from $276.210 to $319.730, which is a 15.76% increase. See the top stocks recommended by …

businessinsider.com

Amgen Shares Remain Market Perform Rated, Leerink Raises Target …

2 weeks from now

Nov 27, 2024  · Amgen's revenue growth of 21.25% over the last twelve months and a quarterly growth of 23.18% in Q3 2024 indicate strong top-line performance, aligning with the firm's …

investing.com

Erste Group Lifts Amgen Stock Rating To Buy On Strong Margins

2 weeks from now

Lastly, Goldman Sachs maintained its Buy rating on Amgen stock with a price target of $370, following discussions with Amgen's management about the company's late-stage pipeline and …

msn.com

Amgen Q4: Good Quarter, Ok Guidance, But MariTide Concerns …

2 weeks from now

1 day ago  · Amgen's Q4 2024 earnings show a 19% revenue increase year-on-year, with non-GAAP EPS up 13% in Q4 and 6% for the full year. Explore more details here.

seekingalpha.com